Sanofi-Aventis Canada Recalls Insulin Products Over Freezing Concerns

Health Canada announced Sanofi-Aventis Canada Inc. is recalling specific lots of insulin pens and cartridges, including Admelog, Apidra, Lantus, Toujeo, and Trurapi. The recall is due to potential freezing damage, which can reduce insulin potency even without visible signs. Patients are advised to verify lot numbers and contact their pharmacy if they possess affected products, impacting those relying on these critical medications.